Status:
COMPLETED
COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease
Lead Sponsor:
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Conditions:
Coronavirus Infection
Eligibility:
All Genders
3+ years
Phase:
NA
Brief Summary
Evaluating the rate of exposure to the virus in the close contact population who shared the home of a person infected with SARS-CoV-2 at the time of infection of the index case - adults or children - ...
Detailed Description
Transmission of the virus is possible from patients without or with very few symptoms. The viral load is high from the onset of symptoms and then decreases to the limit of detection on D21. The period...
Eligibility Criteria
Inclusion
- Index case
- Adult\> 18 years old
- Having presented a SARS-CoV-2 infection confirmed by PCR (INDEX COVID / PCR +)
- or having presented clinical symptoms compatible with the diagnosis of COVID-19 (COVID-like) with at least 3 of the following symptoms for ⩾ 48 hours: fever, cough, anosmia, ageusia, headache, diarrhea, or CT scan with pneumopathy image in frosted glass
- Living at the time of symptoms with at least 2 other people in the same household
- Written consent for himself and for minors for whom he is responsible
- Contact case
- Adult (s) or child (ren), aged 3 to 17 (school age including kindergarten), living in the same household as the index case at the time of the symptoms of the index case
- Written consent for adults
- Consent given by parents for minors
Exclusion
- Patient protected by law (patient under guardianship and guardianship, person deprived of liberty)
- Patient with major cognitive disorders.
Key Trial Info
Start Date :
July 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04511949
Start Date
July 12 2020
End Date
November 30 2020
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Christine KATLAMA
Paris, Île-de-France Region, France, 75013